Therapeutic drug monitoring enables safe and effective lenalidomide therapy in patients with multiple myeloma on hemodialysis.
Kobayashi T et al. Ann Hematol. 2016 Sep 6. [Epub ahead of print].
Mid-term outcomes after radiofrequency-targeted vertebral augmentation in the treatment of myeloma associated vertebral fractures.
Ali T et al. Technol Health Care. 2016 Sep 14;24(5):745-51. doi: 10.3233/THC-161222.
Pharmacokinetics of Cefepime in Patients with Cancer and Febrile Neutropenia in the Setting of Hematologic Malignancies or Hematopoeitic Cell Transplantation.
Whited L et al. Pharmacotherapy. 2016 Sep;36(9):1003-10. doi: 10.1002/phar.1807. Epub 2016 Sep 6.